BANK OF MONTREAL /CAN/ - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 67 filers reported holding IMMUNE DESIGN CORP in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q4 2018$1,0000.0%446
+93.1%
0.00%
Q3 2018$1,0000.0%231
-2.9%
0.00%
Q2 2018$1,000238
+852.0%
0.00%
Q1 2016$0
-100.0%
250.0%0.00%
Q4 2015$1,000250.0%0.00%
Q3 2015$0
-100.0%
250.0%0.00%
Q2 2015$1,0000.0%250.0%0.00%
Q1 2015$1,000250.00%
Other shareholders
IMMUNE DESIGN CORP shareholders Q4 2015
NameSharesValueWeighting ↓
COLUMN GROUP L P 3,161,942$65,294,000100.00%
ProQuest Associates IV LLC 1,983,858$40,967,0008.41%
Iguana Healthcare Management, LLC 150,000$3,098,0000.98%
SECTORAL ASSET MANAGEMENT INC 810,390$16,735,0000.70%
Cormorant Asset Management, LP 189,000$3,903,0000.52%
SPHERA FUNDS MANAGEMENT LTD. 140,000$2,891,0000.28%
RS INVESTMENT MANAGEMENT CO LLC 750,402$15,496,0000.13%
Eventide Asset Management 102,904$2,125,0000.12%
Rock Springs Capital Management LP 55,000$1,136,0000.08%
Focused Wealth Management, Inc 3,406$70,0000.04%
View complete list of IMMUNE DESIGN CORP shareholders